Technology
Musk's Neuralink to start human trial of brain implant
Billionaire entrepreneur Elon Musk's brain-chip startup Neuralink said on Tuesday it has received approval from an independent review board to begin recruitment for the first human trial of its brain implant for paralysis patients.
Those with paralysis due to cervical spinal cord injury or amyotrophic lateral sclerosis may qualify for the study, it said, but did not reveal how many participants would be enrolled in the trial, which will take about six years to complete.
The study will use a robot to surgically place a brain-computer interface (BCI) implant in a region of the brain that controls the intention to move, Neuralink said, adding that its initial goal is to enable people to control a computer cursor or keyboard using their thoughts alone.
The company, which had earlier hoped to receive approval to implant its device in 10 patients, was negotiating a lower number of patients with the US Food and Drug Administration (FDA) after the agency raised safety concerns, according to current and former employees. It is not known how many patients the FDA ultimately approved.
Musk has grand ambitions for Neuralink, saying it would facilitate speedy surgical insertions of its chip devices to treat conditions like obesity, autism, depression and schizophrenia.
In May, the company said it had received clearancefrom the FDA for its first-in-human clinical trial, when it was already under federal scrutiny for its handling of animal testing.
Even if the BCI device proves to be safe for human use, it would still potentially take more than a decade for the startup to secure commercial use clearance for it, according to experts.
-
Technology1d ago
Save $150 on this Dyson air purifier deal before Prime Day
-
Technology1d ago
Save 25% on this BlueAir DustMagnet 5440i air purifier, $80 off at Amazon
-
Technology1d ago
Nuclear rockets could travel to Mars in half the time − but designing the reactors that would power them isn’t easy
-
Technology1d ago
Trees’ own beneficial microbiome could lead to discovery of new treatments to fight citrus greening disease
-
Technology2d ago
Save 20% on Celestron binoculars in this limited time Amazon deal
-
Technology2d ago
One of the best Celestron telescopes now $2,399 in latest Adorama price drop
-
Technology3d ago
These are the cheapest binocular deals ahead of Amazon Prime Day
-
Technology3d ago
Could these camera deals get any better before Amazon Prime Day?